Ethyl butamide and propyl butamide, the active constituents of the analeptic drug named Prethcamide (Ciba-Geigy), undergo biotransformation to respective single metabolites in the presence of rat hepatic microsomes and the NADPH-generating system. Spectral analysis showed that the metabolites were hydroxylated forms of the drug. The hydroxylation was stimulated by NADH and increased ionic strength, and inhibited by the known cytochrome P-450 inhibitors, e.g. SKF-525A, metyrapone, CO and KCN. The drug formed type I binding spectrum with cytochrome P-450.

Download full-text PDF

Source

Publication Analysis

Top Keywords

rat hepatic
8
hepatic microsomes
8
cytochrome p-450
8
study prethcamide
4
prethcamide hydroxylation
4
hydroxylation system
4
system rat
4
microsomes ethyl
4
ethyl butamide
4
butamide propyl
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!